ホーム › 軟部組織肉腫 › マサチューセッツ州 › Boston
Boston、MAにおける軟部組織肉腫の臨床試験
Bostonとその周辺地域（約30マイル以内）の拠点で、軟部組織肉腫に関する18件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Distance-Based Exercise to Preserve Function and Prevent Disability
被験者募集中
- Dana-Farber Cancer Institute, Boston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
被験者募集中第2相
- Dana-Farber Cancer Institute - Oncology Department, Boston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
被験者募集中第1/2相
- Dana Farber Cancer Institute., Boston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
被験者募集中第1相
- Dana-Farber Cancer Institute, Boston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
被験者募集中第1/2相
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
First-in-Human Trial of DS-2243a in Participants With Advanced Solid Tumors
被験者募集中第1相
- Dana-Farber Cancer Institute, Boston
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
被験者募集中第1相
- Dana-Farber Cancer Institute, Boston
Serial MRI Scans During Radiation Therapy
被験者募集中
- Brigham and Women Hospital, Boston
- Dana Farber Cancer Institute, Boston
Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention
被験者募集中
- Boston Children's Hospital, Boston
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
被験者募集中第1/2相
- Dana Farber Cancer Institute, Boston
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
被験者募集中第1/2相
- Dana Farber Cancer Institute, Boston
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
被験者募集中観察研究
- Brigham and Women's Hospital, Boston
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
被験者募集中観察研究
- Dana-Farber Cancer Institute, Boston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
被験者募集中第1/2相
- Massachusetts General Hospital,, Boston
Video Education With Result Dependent dIsclosure
被験者募集中
- Dana Farber Cancer Institute, Boston
Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas
被験者募集中第1/2相
- Boston Children's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
- Brigham and Women's Hospital, Boston
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
REtroperitoneal SArcoma Registry: an International Prospective Initiative
被験者募集中観察研究
- Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston
他の都市における軟部組織肉腫の試験
- Houston, TX32件の研究
- New York City, NY19件の研究
- St. Louis, MO14件の研究
- Los Angeles, CA13件の研究
- Columbus, OH13件の研究
- Washington, DC12件の研究
- Memphis, TN11件の研究
- Philadelphia, PA10件の研究
- Rochester, MN9件の研究
- Nashville, TN9件の研究
- Aurora, CO9件の研究
- Queens, NY9件の研究
Bostonにおける他の研究
- 乳がん111件の研究
- 非小細胞肺癌90件の研究
- がん（全種類）86件の研究
- 大腸癌63件の研究
- 転移性癌63件の研究
- 肺がん62件の研究
- 卵巣がん61件の研究
- 前立腺がん59件の研究
- うつ病52件の研究
- 子宮内膜がん50件の研究
- 心不全44件の研究
- 急性骨髄性白血病44件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。